Clinical practice advice on lifestyle modification in the management of nonalcoholic fatty liver disease in Japan: an expert review Yoshihiro KamadaHirokazu TakahashiJapan Study Group of NAFLD (JSG‐NAFLD) Review 31 October 2021 Pages: 1045 - 1061
A nationwide survey concerning the mortality and risk of progressing severity due to arterial and venous thromboembolism in inflammatory bowel disease in Japan Katsuyoshi AndoMikihiro FujiyaTadakazu Hisamatsu Original Article—Alimentary Tract Open access 05 October 2021 Pages: 1062 - 1079
Multicenter, cross-sectional, observational study on Epstein–Barr viral infection status and thiopurine use by age group in patients with inflammatory bowel disease in Japan (EBISU study) Miki MiuraHirotaka ShimizuTadakazu Hisamatsu Original Article—Alimentary Tract 30 September 2021 Pages: 1080 - 1091
Nationwide survey for patients with acute-on-chronic liver failure occurring between 2017 and 2019 and diagnosed according to proposed Japanese criteria Nobuaki NakayamaHayato UemuraSatoshi Mochida Original Article—Liver, Pancreas, and Biliary Tract 05 November 2021 Pages: 1092 - 1106
Acid suppressants during hospitalization and after discharge in patients after gastroduodenal ESD Yasutoshi ShiratoriRyota NiikuraNaoki Ishii Letter to the Editor 16 October 2021 Pages: 1107 - 1108
Reply to “Acid suppressants during hospitalization and after discharge in patients after gastroduodenal ESD” Hiroko AbeKunio TarasawaAtsushi Masamune Letter to the Editor 15 October 2021 Pages: 1109 - 1110
Correction to: Crohn’s disease-specific mortality: a 30-year cohort study at a tertiary referral center in Japan Shigeyoshi YasukawaToshiyuki MatsuiMasakazu Washio Correction 10 October 2021 Pages: 1111 - 1112